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INTRODUCTION
A
lkaline phosphatase (ALP) is a marker enzyme of microvillus membranes (MVM) 
in intestine and exists both in the soluble and membrane bound forms. The two 
isoforms of the enzyme are encoded by 2.7 and 3.0 kb mRNA transcripts. The isoen-
zymes undergo considerable modification during postnatal development (1, 2). The high 
activity of intestinal ALP , which is localized at the brush border of intestinal epithelial 
cells, suggests the participation of this enzyme in the transport of nutrients such as 
inorganic phosphate across the membrane. Intestinal ALP appears to have an important 
role in active metabolism by hydrolyzing phospho-compounds to supply free inorganic 
phosphate (3).
In the last two decades, several comprehensive investigations of cytotoxic agents have 
shown that intraperitoneally administered 5-fluorouracil (5-FU) induces apoptosis or cell 
cycle arrest in intestinal epithelial cells of experimental animals and tends to target basal 
FHOOVZLWKLQWKHFU\SW7KHLQWHVWLQDOLQMXU\LQFXUUHGLQLVFKHPLDUHSHUIXVLRQVWXGLHV
has conventionally been assessed with histological grading scales. One of the critical 
limitations of these techniques is the inability to differentiate irreversible injury from repa-
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ABSTRACT
Background: One of the critical limitations for the administration of the chemotherapy is the toxic-
ity affecting normal tissue. The main target organs for 5-fluorouracil (5-FU) toxicity in humans and 
experimental animals are the gastrointestinal tract, bone marrow, and skin. The cytotoxic effects of 
antimetabolite chemotherapy are based on their role as substrates for the same transport processes 
and enzymes involved in anabolism and catabolism as the natural substrates. The main goal of our study 
was to analyze the dose-dependent antiproliferative effects of 5-FU on intestinal mucosa, enterotoxic 
potential of 5-FU in experimental animals and to test possible protective role of glutamine.
Methods: In our study, we used Sprague Dawley rats. The control group of rats included 50 animals, while 
the groups where either 5-fluorouracil (5-FU) alone or 5-FU and glutamine were administered included 200 
animals. All experimental animals were further stratified according to the experimental model (25 animals 
in each of 8 experimental subgroups of animals). The 5-FU was administered by intraperitoneal applica-
tion in single dose of 0, 100, 200, 300, and 400 mg of 5-FU per kg of body weight. Water solution of 1% 
glutamine was prepared daily and administered orally, in volume of 200 ml, for 7 days continuously, after 
the 7th day of 5-FU administration. Experimental animals were sacrificed 7 days after the administration 
of 5-FU. The isolation of enterocytes was performed according to the method of Kralovansky et al. In cell 
homogenate obtained by described method, we determined the protein content using the Biuret method 
and the DNA content using the Burton reagent. The activities of enzymes alkaline phosphatase (ALP), gluta-
thione S-transferase (GST), glutathione reductase (GR), and glutathione peroxidase (GPX) were determined 
by kinetic method. All paraffin samples of the small intestine were stained by haematoxiline and eosine (HE stained by haematoxiline and eosine (HE
method). All the experiments were done in duplicate and analyzed by standard statistical methods. All the experiments were done in duplicate and analyzed by standard statistical methods.
Results: Our results of enterotoxicity induced by intraperitonealy administered 5-FU showed statistically 
significant decrease of DNA content in small intestine samples of experimental animals, decrease in 
activity of intestinal alkaline phosphatase enzyme and the increase in glutathione-dependent enzymes.
The glutamine supplementation reduced 5-FU intestinal toxicity. 
Conclusion: Intestinal alkaline phosphatase is a good marker of the dose-dependent enterotoxicity 
induced by 5-fluorouracil.
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rable injury. Both experimental and clinical studies of these phenomena would be greatly 
advanced by the identification of a biochemical marker specific for microvillus injury. Such 
a marker could then be used to delineate factors affecting intestinal injury as well as the 
efficacy of therapeutic interventions (5). Our interest in alkaline phosphatase as a potential 
marker of cytotoxic injury is derived from previous experimental observations by our labora-
tory and from the results of Sisley et al. (5,8).
Few studies have demonstrated that in the rat intestinal brush border membranes, alkaline 
phosphatase activity was highly susceptible to inactivation by free radical injury in an in 
vitro model of lipid peroxidation, whereas other brush border membrane integral enzymes 
including disaccharidases and peptidases were resistant to free radical damage (3,9). Our 
current experiments were designed to evaluate the specificity of the intestinal brush border 
membrane alkaline phosphatase as a potential novel marker for dose-dependent intestinal 
injury and possible mucosal protection by glutamine.
Glutamine, traditionally considered a nonessential amino acid, now appears to be a condition-
ally essential nutrient during serious injury or illness. In good health, this is the most abundant 
amino acid in plasma and skeletal muscle, but circulating and tissue concentrations fall pre-
cipitously after injury, surgery or infection. Glutamine is preferred fuel for the small intestine and 
clinical studies have revealed that both the parenteral and enteral glutamine supplementation is 
beneficial in patients after multiple trauma, and surgery. Studies have shown that utilization of 
glutamine by the gut increases after surgery and other stress conditions and appears to play 
a vital role in gut maintenance during critical illness. These clinical studies are supported by 
experimental data showing that glutamine administration maintains gut barrier function (10).
Glutamine can offer protection to the cells by different mechanisms. Glutamine is utilized as 
a major energy source by the intestinal mucosa and it drives mitochondrial ATP formation by 
oxidative phosphorylation. Uptake of glutamine by the enterocytes occurs from the gut lumen 
across the brush border and from the blood stream via capillaries that are adjacent to the base-
ment membrane. The avid uptake of glutamine by the mucosal cells is due in part to the high 
activity of glutaminase, the first enzyme in the series of reactions that completely oxidizes the 
carbon chain of glutamine to generate energy. Glutamine may also serve as a metabolic precur-
sor for glutathione, the important cellular antioxidant (10). Our previous study (8) showed that 
the glutaminase is not as sensitive marker of enterotoxicity as alkaline phosphatase.
The main goal of our present study was to setup the experimental conditions by testing 
biochemical parameters (enzymes), which may enable follow-up of controlled intestinal 
mucosa damage, induced by 5-FU, as well as to test whether glutamine decreases or 
prevents this damage. Therefore, we presented the results of this investigation.
MATERIAL AND METHODS
In our study, we used Sprague Dawley rats, body weight of 250 g approximately. The control 
group of rats included 50 animals, while the experimental groups where either 5-fluorouracil 
(5-FU) alone or 5-FU and glutamine were administered, included 200 animals. All experimental 
animals were further stratified according to the experimental model (25 animals in each of 8 
experimental subgroups of animals). The animals received standard nutritive formula for rats. 
The 5-FU was administered by intraperitoneal application. Water solution of 1% glutamine was 
prepared daily and administered orally for 7 days after the 5-FU, in volume of 200 ml.
7KHGRVHRI)8DGPLQLVWHUHGZDVPJNJ%:ERG\ZHLJKW)RUWKHDQDO\VLVRIWKH
dose-dependent effects, we decided to follow-up the enzyme activity on 7th day after the 
administration of 0, 100, 200, 300, and 400 mg of 5-FU per kg of body weight.
The experimental animals were sacrificed according to the experimental plan. The animals 
in experimental group, which received only 5-FU, were sacrificed 7 days after the single 
5-FU dose. The animals in the experimental group, which received the single dose of 5-FU 
and 7 days later started to drink fresh glutamine solution, were sacrificed after 7 days of 
oral administration of glutamine.
The isolation of enterocytes was performed according to the method of Kralovansky et al. 
(11). The enterocytes were obtained by “scrapping” method from the 90 cm long intestine, 
starting from the end of duodenum. The mucosa was homogenized in Potter-Elveiheim 
KRPRJHQL]HULQLVRWRQLF.&OZLWKPPROOPHUFDSWRHWKDQRODW&$IWHUWKHFHQWULIXJDWLRQ
on 15000 rpm in Eppendorf centrifuge for the analysis of studied parameters, the super-
natant was used, as well as for the total protein content determination by Biuret method. 
The “scrapping” method provides homogenous experimental material and therefore, all the 
parameters are calculated according to the exactly measured length of the intestines and the 
protein content. The isolated cells were collected in one combined cell fraction. The experi-
mental animals were continually observed and all behavioral changes, toxic gastrointestinal 
damages as well as the survival periods for each animal were recorded.
In cell homogenate obtained by described method, we determined the protein content using 
the Biuret method (12), and the DNA content using the Burton reagent (13). The activities of 
enzymes alkaline phosphatase (ALP), glutathione S-transferase (GST), glutathione reduc-
tase (GR) and glutathione peroxidase (GPX) were determined by kinetic method (13-15).
All samples of the small intestine were fixed in 10% formaldehyde, then put into paraffin, 
cut into 5 µm samples, and stained by haematoxiline and eosine (HE method). The samples µm samples, and stained by haematoxiline and eosine (HE method). The samples 
prepared according to the methodology described above were analysed qualitatively, by 
light microscopy, and the digital cammera was used for the photographs of samples.
All the experiments were done in duplicate. Results are expressed as mean ± standard 
error of the mean (SEM). Differences among means were tested for statistical significance 
by student’s two-tailed t-test. Statistical significance was set at p<0.05.
RESULTS
Our study was aimed to investigate the dose-dependent effects of intraperitoneal admin-
istration of 5-fluorouracil (5-FU) on intestinal toxicity and to test the possible protective 
effects of glutamine. According to the results of our preliminary experiments, we have 
selected the time course and the doses of 5-FU applied intraperitoneally in rats. 
Our results showed that the protective effects of oral administration of 1% glutamine solution 
ZHUHSUHVHQWLQJURXSVRIH[SHULPHQWDODQLPDOVWKDWUHFHLYHGDQGPJ)8NJRI
body mass. The marker of this protective effect was the statistically significant increase in alka-
line phosphatase activity in the samples of intestinal mucosa from the rats which received orally 
the 1% glutamine solution after the intraperitoneal application of 5-FU (Figure 1). The increased 
activity of alkaline phosphate in this group of animals may be the result of the stimulation of cell 
membrane stabilization, induced by oral administration of fresh glutamine solution.
*p<0.05
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Figure 1. The comparison of specific activity of alkaline phosphatase in intestinal mucosa of two 
groups of experimental animals treated by 5-FU, with and without glutamine administration. The statisti-
cally significant differences between two groups are indicated by asterisk.
The effects of the intestinal toxicity induced by 5-FU on DNA content and glutathione-
associated enzymes are shown in figures 2-4. For the analysis of glutathione-associated 
enzymes and for the qualitative histopathological analysis, we selected the animals which ZZZRQNQVDF\X$UFKLYH'HFHPEHU
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UHFHLYHGPJNJ%:RI)8DORQHDQGZLWKJOXWDPLQHDFFRUGLQJWRWKHUHVXOWVRIWKH
activity of alkaline phosphatase in this subgroups of animals.
In Figure 2, we showed that the 5-FU application induced the statistically significant 
decrease of the DNA content in samples of intestinal mucosa homogenates in comparison 
with the samples from animals in control group, for each dose of 5-FU applied. This 
decrease in DNA content was not observed in 5-FU + glutamine subgroups in comparison 
with the control group.
* p<0.05
Figure 2. DNA content in intestinal mucosa homogenate. The statistically significant differences The statistically significant differences The statistically significant differences 
between control and 5-FU subgroups are indicated by asterisk.
7KH)LJXUHLVVKRZLQJWKDWWKHDSSOLFDWLRQRIPJNJ%:RI)8LQGXFHGWKHVWDWLVWL-
cally significant increase of the GR and GPX activity. This increase was even more evident in 
the samples of the animals receiving 5-FU + glutamine, which is a precursor of glutathione, 
the substrate of GR and GPX. The similar dynamics of enzyme activity is shown on Figure 
4, where the application of 5-FU alone and 5-FU + glutamine induced the statistically 
significant increase of the GST activity.
Figure 3. Specific activity of GR and GPX in intestinal mucosa homogenate.
Figure 4. Specific activity of GST in intestinal mucosa homogenate.
Qualitative histopathological analysis of the samples from the control group of animals 
showed that they are the small intestine samples (results not shown). On the surface of the 
intestine, the villi are characterised by adequate height and width, by the presence of cylin-
drical epithelium and adequate number of goblet cells and intraepithelial lymphocytes. The 
brush border is preserved. The crypt space is of adequate height. The crypts are regularly 
distributed and lined by cylindrical epithelium with adequate number of goblet cells. The 
adequate number of mitoses is present in the epithelium of cryptal bases. The lamina pro-
pria is modestly oedematous and slightly infiltrated with lymphocytes and plasma cells.
The samples from the group of animals with intraperitoneal application of 5-fluorouracil, showed that 
they are the small intestine samples. In all samples thin and long villae are present, and covered by 
typical epithelium (Figure 5). The crypts are of adequate depth, but modestly of irregular distribution. 
Some crypts are slightly dilated. Epithelium of crypts is cylindrical, with adequate number of goblet 
cells and modestly increased number of mitoses within the epithelium of cryptal bases (Figure 6).
Figure 5. General view of the small intestine mucosa in the group 5-FU (HE, 10 X 20)
Figure 6. Small intestine crypts in the mucosa of the animals receiving 5-FU (HE, 10 x 40)
In all samples of small intestine from the animals that orally received the glutamine solution after 
the intraperitoneal application of 5-FU, intestinal villae are of adequate height and width, covered 
by cylindrical epithelium with an adequate number of goblet cells and intraepithelial lymphocytes. 
The brush border is preserved (Figure 7). The crypt space is of adequate height. The crypts are 
regularly distributed, with regular diameter, and lined by cylindrical epithelium with adequate 
number of goblet cells. The adequate number of mitoses is present in the epithelium of cryptal 
bases. The lamina propria is slightly infiltrated with lymphocytes and plasma cells (Figure 8). ZZZRQNQVDF\X$UFKLYH'HFHPEHU
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Figure 7. General view of the small intestine mucosa in the group 5-FU + glutamine (HE, 10 X 10)
Figure 8. Small intestine crypts in the mucosa of the animals receiving 5-FU + glutamine (HE, 10 x 40)
DISCUSSION
The current experimental observations in rat intestinal mucosa are consistent with our previ-
ous findings in methotrexate-mediated injury and demonstrate that a reduction in mucosal 
alkaline phosphatase activity appears to be a potential marker of injury induced by antitumor 
drugs (8). This easily assessable enzyme allows a clear distinction between reparable and 
irreversible damage and could prove to be a valuable tool in the further characterization of 
cytotoxic phenomena. Such measurements may prove to be important in the quantitative 
evaluation of therapeutic interventions in human intestinal toxicity and determination of 
tolerable doses of antitumor drugs.
In the relevant animal models described in our study, we found that alkaline phosphatase 
activity was significantly reduced by 5-FU, but not significantly affected after the glutamine 
supplementation. In contrast, glutathione S-transferase, glutathione reductase and glutathi-
one peroxidase, showed the increase in enzyme activity after 5-FU, which is in accordance 
with the findings of other authors that these enzymes are involved in the protection from 
chemically induced intestinal damage (16,17).
The significant dose-dependent decrease in ALP activity in intestinal mucosa may be the 
result of two phenomena: the downregulation of the expression of ALP enzyme and the 
inhibition of DNA synthesis, showed by the decline in DNA content. On the other hand, the 
significant increase in glutathione-dependent enzymes may be the consequence of the up-
regulation of the expression of these enzymes, induced by oxidative stress. It is important 
to emphasize that the glutamine supplementation is very important for the activity of gluta-
thione-dependent enzymes, since the glutamine is one of the three constitutive amino acids 
in glutathione, one of the major parts of cellular antioxidative mechanisms (10,18).
Qualitative histopathological analysis of the small intestine from the animals in the control 
group showed the normal characteristics of the epithelium of villae and crypts, with very 
small number of cells in lamina propria. Therefore, this sample may be considered as 
the normal sample of small intestine. The same finding is present in the sample from the 
animals in the group that only received orally the glutamine solution.
The qualitative analysis of the small intestine samples from the animals in the group that 
intraperitonealy received the bolus dose of 5-FU showed that observed changes were not 
dose-dependent.
By intraperitoneal application of antitumor drugs, direct enterotoxicity is avoided. According 
to the fact that the life cycle of enterocytes is 3-6 days, for the significant histopathological 
changes and for the effects on DNA of enterocytes, the histopathological analysis should be 
performed later than 7 days after the application of 5-FU. After 7 days from the application 
of 5-FU only functional changes of protein synthesis may be present, without morphologi-
cal alterations on cellular level. Our hypothesis is that the morphological changes may be 
visible if using the electron microscopy, such as lowering of the brush border epithelium, or 
the decrease of the number of certain organelles (e.g. rough endoplasmic reticulum). If the 
changes are followed longer, our hypothesis is that we may expect the decrease of the pro-
liferative capacity and of the number of mitoses in the epithelium of crypt bases. It may be 
concluded from our histopathological analysis, that the intraperitoneally administered 5-FU 
mainly exerted its effect on the intestinal cells by systemic exposure from the basal side.
It is well known that the glutathione system is one of the major mechanisms in reducing oxida-
tive stress. Many studies showed that glutamine-supplemented nutrition can enhance tissue 
glutathione levels and that it is associated with improved survival after 5-fluorouracile admin-
istration. Glutamine can act as a source of glutamate in many tissues such as liver or skeletal 
PXVFOHDQGLWKDVEHHQVKRZQWRSUHVHUYHWRWDOJOXWDWKLRQHOHYHOVDIWHULQMXU\LVFKHPLDLQERWK
hepatic and gut models. It has been shown that the gut barrier protection by glutamine could 
possibly be due to glutathione synthesis, by scavenging reactive oxygen intermediates and 
decreasing the formation of free radicals. Glutamine has been shown to induce the expression 
of heat shock proteins (HSP) in intestinal cells and this could be one of the mechanisms of 
protection. Studies have shown that glutamine protection is independent of HSP induction and 
dependent of glutathione augmentation during surgical stress (10,19-21).
Furthermore, a decrease in alkaline phosphatase activity was found to be a good indicator 
for assessing the severity of intestinal injury, which was dose dependent. The above find-
ings clearly demonstrate that intestinal brush border membrane alkaline phosphatase could 
serve as an important marker of toxic injury.
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